hsa-miR-155-3p

ncRNA information

ncRNA name

hsa-miR-155-3p

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

Six1

Cancer information

Cancer name

Glioma

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Temozolomide

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MicroRNA-155-3p promotes glioma progression and temozolomide resistance by targeting Six1

Tissue resource

normal brain tissues and human glioma specimens

human glioma cell lines LN299

human glioma cell lines A172

human glioma cell lines T98

human glioma cell lines U87

human glioma cell lines U251

Experiment

None


Institute

China‚ÄźJapan Union Hospital of Jilin

Cell Bank, the Chinese Academy of Sciences

Country

China

China

Continent

Asia

Asia